Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Toxicon ; 51(3): 345-52, 2008 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-18061641

RESUMO

Human monoclonal antibodies (HuMAbs) against HR1a from Protobothrops (formerly Trimeresurus) flavoviridis venom were obtained by the fusion of SP2/0-Ag14 myeloma cells and spleen cells from KM mice immunized with purified HR1a. The ability of HuMAbs to neutralize the HR1a was determined by in vitro neutralization assay and by neutralization of the hemorrhagic activity. The initial screening of over 300 hybridoma fusion wells resulted in the establishment of 80 HR1a-reactive hybridomas. Of the reactive clones, HuMAb HR1a-7 and HR1a-18 neutralized both proteolytic and hemorrhagic activity of HR1a. Mapping of epitope recognized by the reactive clones was performed by using an ELISA that measured antibody binding to overlapping peptides (15 amino acid peptide offset frameshifted by three residues) covering the metalloproteinase domain sequence of HR1a. HuMAbs HR1a-7 and HR1a-18 neutralized HR1a by reacting with peptides of EQQRYLNNFRFIELV and IVNTLNETYRYL. The three-dimensional structure of HR1a based on a homology modeling predicted that these two epitopes are surface exposed.


Assuntos
Anticorpos Monoclonais/farmacologia , Metaloproteases/antagonistas & inibidores , Venenos de Víboras/enzimologia , Viperidae , Sequência de Aminoácidos , Animais , Anticorpos Monoclonais/imunologia , Mapeamento de Epitopos , Humanos , Hibridomas , Masculino , Metaloproteases/química , Metaloproteases/imunologia , Metaloproteases/metabolismo , Camundongos , Modelos Moleculares , Dados de Sequência Molecular , Testes de Neutralização , Conformação Proteica , Venenos de Víboras/antagonistas & inibidores , Venenos de Víboras/imunologia
2.
Toxicol In Vitro ; 17(2): 169-77, 2003 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-12650671

RESUMO

Okinawa Habu (Trimeresurus flavoviridis) venom is well known for its toxic efficacy, from which one kind of specific protein, Okinawa Habu apoxin protein-1 (OHAP-1) has been extracted. The purpose of this study was to investigate whether OHAP-1 could induce apoptosis in some glioma cells, and if so, to elucidate the possible mechanism involved. Three malignant glioma cell lines were tested. The malignant glioma cell lines were rat C6 and human RBR 17T, U251. OHAP-1 inhibited growth of all cell lines. Whether or not the apoptosis had been induced was determined by using DNA gel electrophoresis, DNA flow cytometry and TUNEL assay. After OHAP-1 treatment, DNA fragmentation, an increase in the percentage of subdiploid DNA content, and TUNEL positive cells were found in the C6, RBR17T, and U251 cells. Furthermore, OHAP-1 showed L-amino acid oxidase (LAAO) activity. In order to study the mechanism of apoptosis induced by OHAP-1, the changes of intracellular reactive oxygen species (ROS) were measured using flow cytometry, and the expression of p53 protein was examined using immunohistochemistry. OHAP-1 was found to generate ROS and increase the expression of p53 protein in glioma cells. The inhibiting effect of OHAP-1 on three tested cells was reversed when an antioxidant of either catalase or reduced glutathione (GSH) was added; its apoptotic effect correspondingly became weaker. In this study, the apoptotic effect of OHAP-1 on some malignant glioma cells was confirmed, and it could be that this effect might be mediated through promoting the generation of intracellular ROS and p53 protein expression in glioma cells. It was suggested that OHAP-1 is promising as a potential candidate for clinical tumor therapy.


Assuntos
Apoptose/efeitos dos fármacos , Venenos de Crotalídeos/farmacologia , Glioma/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Trimeresurus , Aminoácido Oxirredutases/metabolismo , Aminoácido Oxirredutases/farmacologia , Animais , Anticorpos Monoclonais , Antineoplásicos/farmacologia , Sobrevivência Celular/efeitos dos fármacos , Venenos de Crotalídeos/enzimologia , Fragmentação do DNA/efeitos dos fármacos , Eletroforese em Gel de Poliacrilamida , Glioma/patologia , Humanos , Marcação In Situ das Extremidades Cortadas , L-Aminoácido Oxidase , Ratos , Espécies Reativas de Oxigênio/metabolismo , Células Tumorais Cultivadas/efeitos dos fármacos , Células Tumorais Cultivadas/metabolismo , Células Tumorais Cultivadas/patologia , Proteína Supressora de Tumor p53/imunologia , Proteína Supressora de Tumor p53/metabolismo
3.
Toxicon ; 40(4): 441-6, 2002 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-11738237

RESUMO

This study was made to investigate whether Chiropsalmus Quadrigatus toxins (CqTX), which isolated from box jellyfish C. Quadrigatus venom, could induce apoptosis in human U251 and rat C6 malignant glioma cells and transformed vascular endothelial ECV 304 cell lines. Cell viability was estimated by MTT assay. Apoptosis was evaluated using TdT (terminal deoxynucleotidyl transferase)-mediated dUTP nick-end labeling (TUNEL) method and DNA gel electrophoresis. Furthermore, the expression of p53 protein was examined immunohistochemically in the U251 cells. After the CqTX treatment, the growth of all cell lines was inhibited, the fragmented DNA was observed and some cells became TUNEL positive. The expression of p53 protein was increased in the tested U251 cells. The results suggested that CqTX induced apoptosis in these cell lines. The promotion of the p53 expression might be one mechanism of apoptosis induced by CqTX in the glioma cells.


Assuntos
Apoptose/efeitos dos fármacos , Neoplasias Encefálicas/patologia , Venenos de Cnidários/farmacologia , Endotélio Vascular/efeitos dos fármacos , Glioma/patologia , Proteína Supressora de Tumor p53/biossíntese , Animais , Sobrevivência Celular , DNA Nucleotidilexotransferase/metabolismo , Eletroforese em Gel Bidimensional , Endotélio Vascular/citologia , Regulação da Expressão Gênica , Humanos , Imuno-Histoquímica , Marcação In Situ das Extremidades Cortadas , Células Tumorais Cultivadas/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA